Skip to content
City of London

GSK Poaches Top AstraZeneca Dealmakers to Boost Drug Pipeline

Updated on

GSK Plc has hired two top dealmakers from AstraZeneca Plc as the British company seeks to boost its pipeline of cancer therapies and other drugs. 

Chris Sheldon, who has been at AstraZeneca for nearly two decades, will join GSK as a senior vice president leading the commercial aspects of its business development, the company said in an emailed response to queries Wednesday.